ABD-147

N/A

Report date: 2025/09/15 17:59:58

Base Information

Drug NameABD-147

Drug Alias NameABD-147225Ac-ABD147

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Actinium > 225Ac +[4]

Mechanisms of ActionIonising radiation emittersDelta-like protein 3 modulators

TargetsDelta-like protein 3

Therapy Area/IndicationsSolid tumoursSmall Cell Lung CarcinomaNeuroendocrine Tumors

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAbdera Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesAbdera Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsSolid tumoursSmall Cell Lung CarcinomaNeuroendocrine Tumors

Inactive IndicationsN/A

Other Information

ATC CodeN/A